Clinical Trials Browser

Adenocarcinoma × PEGPH20 × Tumor-Agnostic × Clear all

NCT02487277 2020-01-02

PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Phase 2 Terminated

3 enrolled 8 charts

Adenocarcinoma